ADC Therapeutics (ADCT) Non Operating Income (2021 - 2026)
ADC Therapeutics (ADCT) posted quarterly Non Operating Income of -$7.7 million for Q1 2026, up 22.56% year-on-year from -$6.3 million in Q1 2025, and up 22.75% on a QoQ basis from -$10.0 million in Q3 2025.
ADC Therapeutics (ADCT) Non Operating Income (2021 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported Non Operating Income for 6 consecutive years, with -$7.7 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | -7.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.72 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Jun 30, 2025 | -11.25 Mn |
| Mar 31, 2025 | -9.97 Mn |
| Sep 30, 2024 | -8.06 Mn |
| Jun 30, 2024 | -6.67 Mn |
| Mar 31, 2024 | -12.14 Mn |
| Sep 30, 2023 | -9.25 Mn |
| Jun 30, 2023 | -13.00 Mn |
| Mar 31, 2023 | -3,000.00 |
| Sep 30, 2022 | -37.12 Mn |
| Jun 30, 2022 | 12.88 Mn |
| Mar 31, 2022 | 13.44 Mn |
| Sep 30, 2021 | -9.36 Mn |
| Jun 30, 2021 | 693,000.00 |
| Mar 31, 2021 | 21.23 Mn |